These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 10341603)

  • 1. [Methodology of meta analysis and internal diseases-- therapy of hypertension complicated by diabetes as an example].
    Nago N; Tsutani K
    Nihon Naika Gakkai Zasshi; 1999 Feb; 88(2):355-61. PubMed ID: 10341603
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis.
    Varughese GI; Lip GY
    J Hum Hypertens; 2005 Nov; 19(11):851-3. PubMed ID: 16079882
    [No Abstract]   [Full Text] [Related]  

  • 3. [Control of blood pressure in prevention of hypertensive end-organ damage].
    Kido M; Ando K; Fujita T
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():389-93. PubMed ID: 15171405
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of hypertension in the elderly].
    Hohage H; Gerhardt U; Suwelack BM
    Med Klin (Munich); 2003 Sep; 98(9):511-21. PubMed ID: 14551708
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to the JNC VI guidelines for the treatment of hypertension in the resident clinic.
    Naiman DJ; Barker LR
    Md Med J; 1999; 48(6):307-11. PubMed ID: 10628133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current state of beta blockers in hypertension therapy.
    Lardizabal JA; Deedwania PC
    Indian Heart J; 2010; 62(2):111-7. PubMed ID: 21180299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for people with diabetes: a misleading inference in a recent meta-analysis?
    Martin-Carrillo P; Añino A; Pinar O; Fernandez I; Saenz A; Ausejo M
    Diabetes Res Clin Pract; 2010 Oct; 90(1):e1; author reply e2. PubMed ID: 20675004
    [No Abstract]   [Full Text] [Related]  

  • 8. [Highlights 2008 in a university hospital-based internal medicine: the point of view from the chief residents].
    Wilson P; Bullani R; Cosma M; Deriaz S; Donzé J; Monney C; Neuffer N; Pantet O; Roduit J; Schwab M; Méan M
    Rev Med Suisse; 2009 Jan; 5(188):238-43. PubMed ID: 19267051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [IQWIG Preliminary Report: Diuretics are the best antihypertensives. How does it go on with the high blood pressure therapy? (interview)].
    Sawicki P; Anlauf M; Haller H
    MMW Fortschr Med; 2007 Mar; 149(10):6-8. PubMed ID: 17408035
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quality aspects in internal medicine--from anamnesis to meta-analysis].
    Battegay M; Martina B; Bucheli B; Wagner P; Battegay E; Bucher HC
    Praxis (Bern 1994); 1998 Dec; 87(51-52):1785-92. PubMed ID: 10025151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Large clinical intervention trial meta-analysis].
    Matsuoka H
    Nihon Rinsho; 2000 Feb; 58 Suppl 2():13-6. PubMed ID: 11028285
    [No Abstract]   [Full Text] [Related]  

  • 12. [Critical analysis of individual data in meta-analysis. Apropos of an experience in the domain of drug treatment in arterial hypertension].
    Gueyffier F; Boissel JP
    Therapie; 1997; 52(1):29-35. PubMed ID: 9183920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The "Furberg bias" or: about the arbitrary handling of evidence-based medicine].
    Middeke M
    Dtsch Med Wochenschr; 2001 Feb; 126(6):151-2. PubMed ID: 11233884
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation criteria for bronchial carcinoma. How to read a meta-analysis?].
    Paesmans M
    Rev Mal Respir; 2006 Nov; 23(5 Pt 3):16S105-16S111. PubMed ID: 17268346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The practice guideline 'Hypertension' (third revision) from the Dutch College of General Practitioners; a response from the perspective of internal medicine].
    Wiersma T; Walma EP; Thomas S
    Ned Tijdschr Geneeskd; 2004 May; 148(20):1009. PubMed ID: 15181728
    [No Abstract]   [Full Text] [Related]  

  • 17. Beta-blockers should remain as first-line therapy in the management of hypertension.
    Krum H
    Int J Clin Pract; 2008 Aug; 62(8):1137-41. PubMed ID: 18705818
    [No Abstract]   [Full Text] [Related]  

  • 18. INDANA: a meta-analysis on individual patient data in hypertension. Protocol and preliminary results.
    Gueyffier F; Boutitie F; Boissel JP; Coope J; Cutler J; Ekbom T; Fagard R; Friedman L; Perry HM; Pocock S
    Therapie; 1995; 50(4):353-62. PubMed ID: 7482389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Large-scale trials in hypertension: clinical relevance and evaluation].
    Tsukiyama H; Okada K
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():387-95. PubMed ID: 16981569
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of meta-analyses on clinical practice: the benefits.
    Morganti A
    J Nephrol; 2007; 20 Suppl 12():S1-3. PubMed ID: 18050136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.